Although response rates were higher in platinum naïve setting [42, 43], these studies were performed in non-selected populations and as such the role of PIK3CA or PTEN alterations in predicting response to mTOR inhibitors in HNSCC is not clearly known. Here, PIK3CA is linked to head and neck squamous cell carcinoma.